% | $
Quotes you view appear here for quick access.

Elite Pharmaceuticals, Inc. Message Board

  • meifud meifud Apr 19, 2013 8:47 AM Flag

    FDA just shot down EKI-154 even as elite worked feverishly on bilogical equivalency studies

    the studies were to show that elite's generic would be identical to Purdue's oxycontin

    that is EXACTLY what the FDA just banned

    and pumpers say that is good for elite -- after elite has spent years and years working on their generic, and it could have become their first meaningful drug in very short order


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • They will ADD their unique and superior 2 bead ART to ELI-154 which makes it ELI_216 which the FDA and the GOverment want BADLY because NO ONE will be able to sell the old style oxy. Elite will not have much competition now they will catch up and surpass purdue and pfizer they have ran techlology

      Sentiment: Strong Buy

    • elite had even produced large batches of the stuff just to show they had the capability
      what a waste of time, money, and focus
      too bad FDA took this action because a generic oxycontin could have been a quick money maker for elite

0.17+0.01(+3.66%)Oct 24 3:59 PMEDT